← Eichor
Study identifier: NCT05711446 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Double Voiding and Post-transplant UTI

Condition: Urinary Tract Infections · Kidney Transplant; Complications  ·  Sponsor: Weill Medical College of Cornell University

PhaseNA
Planned participants438
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Urinary tract infections (UTI) are common in kidney transplant recipients and are an important cause of illness and hospital admissions. Past studies have shown that about 1 out of 5 of newly transplanted patients develop UTI within their first 3 months of transplantation. Such UTIs increase the risk for blood stream infection and acute rejection of the kidney, Improvements in urinary voiding techniques may reduce the frequency of UTI. The purpose of this study is to evaluate the benefits of "double voiding" in kidney transplant recipients.

This description comes directly from the study's public registry record.

Talk to the study team

Muthukumar Thangamani, M.D.  ·  212-746-9074  ·  mut9002@med.cornell.edu

Ananda Kimm-Drapeau  ·  212-746-6137  ·  alk4031@med.cornell.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Weill Cornell Medical College / NY PresbyterianNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05711446